Stockreport

Zevra Therapeutics Inc (ZVRA) Q3 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF The consensus estimate for Q3 2024 revenue is $4.87 million, and the earnings are expected to come in at -$0.42 per share. The full year 2024's revenue is expected to be [Read more]